American Herbal Products Association (AHPA) > About Us > Committees > Government Relations Committee

Government Relations Committee

Chairperson: Staci Eisner (Cortex Scientific)
Staff Contact: Michael McGuffin

Committee Purpose: To monitor legislative and regulatory issues and agencies for the purpose of developing industry positions that conform to AHPA's mission.

AHPA Members, if you would like to join this committee, please email the staff contact.

 

Committee Meeting Minutes

March 7, 2019 Meeting Minutes

Meeting of the Government Relations Committee

AHPA Members log in to download the meeting minutes.

September 28, 2017 Meeting Minutes

Meeting of the Government Relations Committee

AHPA Members log in to download the meeting minutes.

September 28, 2017 Meeting Minutes

Joint meeting of the Analytical Laboratories, Botanical Raw Materials, And Standards Committees

AHPA Members log in to download the meeting minutes.
RSS
12

Committee-Related News

Dietary supplement recalls are relatively infrequent according to recent FDA data

Dietary supplement recalls are relatively infrequent according to recent FDA data

Two percent of more than 800 recalls initiated in 2019 involved dietary supplement products

Recall data from the Food and Drug Administration (FDA) shows that 14 of 803 (1.7 percent) recorded recalls initiated in 2019 involved dietary supplements, and among these, three were Class I recalls (the most serious recall class), according to an article published in the August 2019 AHPA Report.
August 2019 AHPA Report: Data shows supplement recalls are relatively infrequent, insights from the Hemp-CBD Supplement Congress, Prop 65 enforcement data and more

August 2019 AHPA Report: Data shows supplement recalls are relatively infrequent, insights from the Hemp-CBD Supplement Congress, Prop 65 enforcement data and more

AHPA Members, Log in to access the AHPA Report

The August 2019 AHPA Report includes an analysis of FDA recall data, recent CA Prop 65 enforcement trends, the first warning letter addressing FSVP, insights from the Hemp-CBD Supplement Congress and updated guidance for hemp-CBD.

CO Gov Jared Polis charts course for CBD and hemp innovation at sold-out AHPA Supplement Congress

CO Gov Jared Polis charts course for CBD and hemp innovation at sold-out AHPA Supplement Congress

USDA and FDA officials share key information for companies selling hemp-CBD in dietary supplements

Colorado Governor Jared Polis rallied more than 200 hemp farmers, manufacturers, producers, retailers, and industry professionals during his keynote address to the American Herbal Products Association (AHPA) Hemp-CBD (cannabidiol) Supplement Congress held earlier this month.

July 2019 AHPA Report: McGuffin celebrates 20 years, CBD Advocacy, IADSA, AHPA in the News and more

AHPA Members, Log in to access the AHPA Report

The July 2019 AHPA Report includes an open letter from AHPA President Michael McGuffin on his 20 years as AHPA President, recent CBD advocacy, AHPA's recommendations for supplement innovation, AHPA email alerts and much more.

CA Prop 65 Guidance for Hemp Products

Regulatory and liability implications of Proposition 65 for hemp and hemp-derived products

AHPA has published Guidance on California Proposition 65 and Hemp Products to educate the hemp industry about the regulatory and liability implications of Proposition 65 for hemp and hemp-derived products, including cannabidiol (CBD), sold in the State of California.
Michael McGuffin Celebrates 20 years as AHPA President

Michael McGuffin Celebrates 20 years as AHPA President

An Open Letter to the Membership

It is my heartfelt honor to address you today on the 20th anniversary of the date I began my role as President of the American Herbal Products Association. We have accomplished so much together since 1999!

AHPA urges FDA to protect consumers by quickly clarifying hemp-CBD regulations

Existing supplement and food regulations are sufficiently robust for hemp-derived ingredients

The American Herbal Products Association (AHPA) urged the Food and Drug Administration (FDA) last week to protect consumers by quickly taking specific actions to clarify the regulatory status of hemp and hemp-derived ingredients used in dietary supplements and foods that contain cannabidiol (CBD).

AHPA recommends FDA implement policies to support innovation

The American Herbal Products Association (AHPA) submitted extensive and specific policy recommendations on July 15 to the Food and Drug Administration (FDA) to support responsible dietary supplement innovation while preserving and strengthening FDA’s ability to efficiently and effectively protect the public from unsafe and unlawful products.

Revised Hemp-CBD Status Report

How hemp and CBD companies are impacted by passage of the Farm Bill

Congress passed a Farm Bill in 2018 that included historic provisions to legalize hemp, the low THC cultivars of the Cannabis sativa L. species. This landmark legislation changes how hemp and hemp-derived products like cannabidiol (CBD) are regulated in the U.S. To help the herbal products industry understand the new regulatory landscape, AHPA has expanded this Status Report and to answer industry questions about the new legal landscape.

Sen. Wyden urges HHS-FDA to issue interim final rule for lawful use of CBD in food and dietary supplements

Sen. Wyden urges HHS-FDA to issue interim final rule for lawful use of CBD in food and dietary supplements

Sen. Wyden's request aligns with AHPA's hemp-CBD advocacy

Sen. Ron Wyden (D-OR), a co-author of the hemp provisions included in the 2018 Farm Bill, sent letters to Food and Drug Administration (FDA) Commissioner Ned Sharpless and Health & Human Services (HHS) Secretary Alex Azar urging the agencies to promptly create a regulatory pathway to use cannabidiol (CBD) as a food additive and as a dietary ingredient in dietary supplements.
RSS
1234567